Preliminary efficacy and safety of YSCH-01 in patients with advanced solid tumors: an investigator-initiated trial.

Yandong HeXuhong HuangXiaoxia LiHongwei LiuMin LiuJunjia TaoYuanzhou ShanHafiz Khuram RazaYanqiu LiuWenting ZhongXue-Ping CaoYuan-Yuan YangRuimei LiXian-Long FangKang-Jian ZhangRong ZhangFeng Liu

Published in: Journal for immunotherapy of cancer (2024)

NCT05180851.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
open label
randomized controlled trial